DANIEL B. CHASTAIN

Daniel B. Chastain is a Clinical Associate Professor at the University of Georgia College of Pharmacy, specializing in Clinical Pharmacy and Infectious Diseases. His clinical role includes serving as a Clinical Pharmacy Specialist in Infectious Diseases in Albany, GA. His research focuses on antimicrobial stewardship, fungal infections, HIV treatment, and the impact of immunosuppressive therapies on opportunistic infections. Dr. Chastain’s work addresses critical areas such as candidemia epidemiology, climate change effects on fungal pathogens, and optimizing pharmacotherapy in immunocompromised populations. He actively collaborates with global research networks to analyze outcomes of viral, fungal, and bacterial infections in diverse patient cohorts. His recent studies explore substance use disorders in outpatient antimicrobial therapy, toxoplasmosis serology implications, and the role of pharmacists in interprofessional care.

Dr. Chastain’s publications emphasize real-world clinical data analysis, with a focus on infectious diseases, mycology, and public health strategies. His research spans topics such as CAR-T cell therapy-related infections, post-COVID-19 candidemia trends, and improving diagnostic accuracy through biomarkers like the ferritin-procalcitonin ratio. He advocates for advancing pharmacist roles in critical care settings and addressing health disparities through medication access and education.

His clinical and academic contributions are rooted in evidence-based practice, with a commitment to translating research into actionable guidelines for patient care. Dr. Chastain’s affiliations include the University of Georgia’s Center for Drug Discovery and collaborative networks in global biomedical research.